S4 Medical

S4 Medical announces the exciting news of an additional FDA 510(k) approval and commercial launch of its esolution esophageal deviation device. esolution is the first and only device indicated to reduce the risk of thermal injury to the esophagus in any AF ablation procedure.

The atrial fibrillation community looks forward to an explanation of the "unanticipated observations" associated with PFA.

Cryoablation is an important procedure?for treating patients with atrial fibrillation. The recent Safety Alert on POLARx reporting atrial-esophageal fistulas—the majority of which were fatal—highlights the seriousness of?ablation-related thermal injury. S4 Medical’s esolution?? device is the first FDA-cleared esophageal protection device that reduces thermal injury, and the ONLY device indicated for use in cryoablation procedures. https://lnkd.in/gNQV49ir

Why should we be concerned about AEFs in ablation? While rare, these complications present weeks later and carry a high mortality rate. EPs and colleagues should be aware of the signs to diagnose and address AEF as quickly as possible. #EPeeps #Ablation #AFib Learn more about how the esolution device protects the esophagus in ablation procedures: s4medical.com

Is enthusiasm clouding judgment toward PFA? Not all EPs are convinced it is the golden highway to reducing esophageal injury, and procedural speed and cost are additional considerations. https://lnkd.in/gkX2dUPM #EPeeps #atrialablation

S4 Medical was the topic of “The Lead Podcast by Heart Rhythm Society: Episode 57.” Three electrophysiologists discuss the significance and main points of S4 Medical’s EASY AF IDE study and its esolution device. EASY AF was the first and only randomized, multicenter, prospective clinical trial with EGD as primary endpoint. No adverse events were associated with the use of esolution and the IDE was stopped early due to meeting the primary endpoint. You can earn .25 ACE credit by listening via HRS: https://lnkd.in/epqPSyaN Or you listen on Apple Podcasts: https://lnkd.in/eHQqxids #EPeeps #HRS

We are enjoying meeting many of you Heart Rhythm Society 2024 and providing demos of the esolution esophageal retractor - the first and only FDA-cleared device that reduces the risk of ablation-related esophageal injury during treatment of atrial fibrillation. Stop by to see us at Booth 1459. #EPeeps #HRS2024 #AFib

Heart Rhythm Society 2024 is only 2 days away! We look forward to seeing you there and providing a demo of the esolution esophageal deviation device to reduce thermal injury in ablation procedures. Booth 1459 - see you soon! #EPeeps #AtrialFibrillation #ImprovingOutcomes

Just before #HRS2024 is the Stanford Biodesign New Arrhythmia Tech Retreat. Look for our segment on the esolution esophageal deviation device, demonstrated to reduce thermal injury during ablation for #AFib using any energy source. Al-Ahmad, Amin Stanford Byers Center for Biodesign #EPeeps https://lnkd.in/gKRFntpn

Attending #HRS2024? Stop by booth 1459 to learn more about #esolution - the first and only FDA-cleared device indicated for use with any ablation energy source to deviate the esophagus and reduce the risk of thermal injury during treatment of atrial fibrillation. See you soon! #Afib #EPeeps #Outcomes